Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210035702 210007780 0.99 106.5 Adjuvant (A) 2017-11-30 2017-12-09 Methotrexate intrathecal Y N 210014025 METHOTREXATE INTRATHECAL
210035703 210007789 null 19.3 Curative (C) 2018-07-01 2018-07-01 Methotrexate Intrathecal (any age) N N 210014046 METHOTREXATE INTRATHECAL
210035704 210007795 0 15.45 null 2015-04-02 2015-04-02 Methotrexate Intrathecal (any age) Y N 210014054 METHOTREXATE INTRATHECAL
210035705 210007804 0 76 Curative (C) 2016-09-15 2017-08-21 Methotrexate intrathecal Y N 210014064 METHOTREXATE INTRATHECAL
210035706 210007808 1.18 80.5 Adjuvant (A) 2016-04-02 2016-07-07 Methotrexate intrathecal N N 210014068 METHOTREXATE INTRATHECAL
210035707 210019152 1.75 null null 2014-10-15 2014-10-29 Methotrexate intrathecal N N 210014072 METHOTREXATE INTRATHECAL
210035708 210007822 0 98.5 Curative (C) 2019-02-03 2018-08-23 Methotrexate intrathecal null N 210014084 METHOTREXATE INTRATHECAL
210035709 210007828 null 24.4 Adjuvant (A) 2015-01-24 2015-08-03 Methotrexate intrathecal N N 210014089 METHOTREXATE INTRATHECAL
210035710 210026287 1.71 18.25 Curative (C) 2018-02-01 2018-02-04 Methotrexate Intrathecal (any age) Y N 210014098 METHOTREXATE INTRATHECAL
210035711 210007841 0.87 23.95 Curative (C) 2017-03-20 2018-02-02 Methotrexate intrathecal N null 210014139 METHOTREXATE INTRATHECAL
210035712 210026291 0 52.2 Curative (C) 2016-02-24 2016-04-06 Methotrexate intrathecal Y N 210014166 METHOTREXATE INTRATHECAL
210035713 210007856 1.55 74 null null 2014-05-16 UKALL14- Ph 2 Induction N N 210014168 UKALL2014
210035714 210019168 1.74 52.7 Curative (C) 2015-12-09 2015-12-10 UKALL 14 TRIAL Y N 210014190 UKALL2014
210035715 210019172 1.78 94.4 Curative (C) 2018-04-07 2018-04-08 UKALL 14 TRIAL Y N 210014253 UKALL2014
210035716 210007886 1.75 90 Curative (C) 2016-08-15 2016-12-10 UKALL14- Ph 2 Induction 1 null 210014260 UKALL2014
210035717 210007891 1.94 96.2 Curative (C) 2016-05-08 2016-10-18 UKALL14- Ph 2 Induction N N 210014273 UKALL2014
210035718 210007900 1.64 73 Curative (C) null 2015-05-04 UKALL 14 TRIAL N null 210014286 UKALL2014
210035719 210007905 1.63 73.3 Adjuvant (A) 2016-02-01 2016-05-29 UKALL14- Maintenance Y N 210014295 UKALL2014
210035720 210007915 1.67 85 Curative (C) 2014-08-16 2014-08-21 UKALL14- Intens/CNS Proph +Imatinib Y N 210014311 UKALL2014
210035721 210030544 1.64 58.3 Curative (C) 2015-11-24 2016-02-21 UKALL14- Ph 2 Induction Y N 210014314 UKALL2014
210035722 210007926 1.67 55.4 Curative (C) 2017-07-05 2017-07-10 UKALL14- Ph 2 Induction + Imatinib N N 210014320 UKALL2014
210035723 210007939 1.55 54.4 Disease modification (D) 2015-11-05 2016-06-27 UKALL14- Intens/CNS Proph 01 N 210014366 UKALL2014
210035724 210007947 null 71.2 Curative (C) 2015-10-07 2015-10-07 UKALL14- Intens/CNS Proph null null 210014387 UKALL2014
210035725 210007957 1.57 80 Curative (C) 2013-09-23 2015-12-05 UKALL14- Ph 2 Induction Y null 210014406 UKALL2014
210035726 210019193 1.82 101.7 Curative (C) 2014-11-08 2014-11-08 UKALL14- Intens/CNS Proph N N 210014446 UKALL2014
210035727 210007968 1.83 141.9 Curative (C) 2016-04-02 2016-09-01 UKALL14- Cons Cycle 1 y N 210014450 UKALL2014
210035729 210007979 1.6 67 Curative (C) 2015-03-23 2015-03-31 UKALL14- Ph 1 Induction Y N 210014466 UKALL2014
210035730 210007988 1.66 103.5 Curative (C) null 2013-09-07 UKALL 14 TRIAL Y N 210014481 UKALL2014
210035731 210007994 1.95 97.8 Curative (C) 2013-08-05 2014-01-26 UKALL14- Ph 1 Induction Y Y 210014493 UKALL2014
210035732 210007998 1.83 89.7 Palliative (P) 2018-02-23 2018-04-04 UKALL14- Ph 2 Induction Y 0 210014497 UKALL2014
210035734 210008017 1.87 60.7 Curative (C) 2016-01-04 2016-08-13 UKALL14- Maintenance 1 N 210014505 UKALL2014
210035735 210008021 1.7 99.5 Curative (C) 2016-06-29 2016-07-01 UKALL14- Intens/CNS Proph null N 210014510 UKALL2014
210035736 210008025 null 93.8 Palliative (P) 2014-03-18 2014-05-05 UKALL14- Maintenance Y null 210014515 UKALL2014
210035737 210008030 1.61 43.6 Curative (C) 2016-01-01 2016-01-05 UKALL14- Intens/CNS Proph Y N 210014519 UKALL2014
210035738 210030549 1.71 74.2 Curative (C) 2015-07-04 2016-03-19 UKALL14- Cons Cycle 1 N N 210014536 UKALL2014
210035739 210008041 null 92 Curative (C) 2014-04-10 2014-10-28 UKALL14- Cons Cycle 1 Y null 210014554 UKALL2014
210035740 210030550 1.76 83 Curative (C) null 2019-03-28 UKALL14- Cons Cycle 1 Y N 210014561 UKALL2014
210035741 210008050 1.92 85 Curative (C) 2014-12-23 2015-09-03 UKALL 14 TRIAL Y N 210014576 UKALL2014
210035742 210008060 1.49 54.6 Curative (C) 2015-06-28 2015-09-22 UKALL14- Intens/CNS Proph 01 N 210014595 UKALL2014
210035743 210008068 1.76 57.8 Curative (C) 2015-11-27 2015-11-28 UKALL14- Maintenance N null 210014607 UKALL2014
210035746 210019235 1.62 118.2 Curative (C) 2013-11-01 2014-06-18 UKALL14- Intens/CNS Proph N N 210014626 UKALL2014
210035747 210008090 1.63 71.7 Curative (C) 2013-07-18 2014-05-18 UKALL14- Cons Cycle 1 Y null 210014651 UKALL2014
210035749 210008111 1.94 93.2 Curative (C) 2018-11-20 2019-01-12 UKALL14- Ph 2 Induction + Imatinib 1 N 210014674 UKALL2014
210035750 210008116 1.54 78.3 Curative (C) null 2017-05-15 UKALL14- Maintenance Y N 210014676 UKALL2014
210035751 210008133 1.77 92.8 Curative (C) 2014-05-23 2014-11-23 UKALL14- Cons Cycle 1 01 N 210014747 UKALL2014
210035752 210019253 1.75 61.8 Curative (C) 2015-09-25 2016-03-02 UKALL 14 TRIAL Y null 210014757 UKALL2014
210035753 210008153 1.72 67.8 Curative (C) 2018-03-07 2018-03-13 UKALL14- Maintenance 02 N 210014775 UKALL2014
210035754 210008160 1.72 51.2 Curative (C) 2016-04-09 2017-03-03 UKALL14- Maintenance Y N 210014779 UKALL2014
210035756 210008175 1.57 79.8 Curative (C) 2016-08-07 2017-03-20 UKALL14- Maintenance Y N 210014839 UKALL2014
210035757 210008181 1.76 70.15 Curative (C) 2016-11-27 2016-11-27 UKALL 14 TRIAL 01 N 210014841 UKALL2014